Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists hunt clues to unlock mystery of Immunotherapy's dangerous side effects

NCT ID NCT05331066

Summary

This study aims to understand why some cancer patients develop serious side effects from immunotherapy drugs called checkpoint inhibitors. Researchers will follow 200 patients with solid tumors who are starting this treatment, collecting blood, stool, and sometimes skin samples over time. The goal is to find biological clues that might predict who is at risk for these side effects before they happen.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Royal Marsden NHS Foundation Trust

    RECRUITING

    Chelsea, London, SW3 6JJ, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.